Blog

October 29, 2021

Overcoming Challenges Related to Multiple Sclerosis Treatment: Initiating Treatment

OptimizeRx

Part Two of Our Multiple Sclerosis Series In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is awareness. A lack of awareness on the part of primary care physicians,...

October 8, 2021

Omnichannel Strategy Insights from Digital Pharma East 2021

Angelo Campano

Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true omnichannel experience for HCPs. That’s why I was excited to present...

September 21, 2021

Access and Affordability Trends in Rare and Orphan Disease

Audrey McConnell

An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less than 200,000 people1. Orphan diseases, including rare diseases, are...

July 13, 2021

Advancing Oncology Treatment and Health Equity – An ASCO Recap

Audrey McConnell

The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights from this year’s cutting-edge research presentations. The theme of this year’s...

May 26, 2021

OptimizeRx Specialty Solutions: Technology that Optimizes Your Access Support Ecosystem

Audrey McConnell

As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of my research career was seeing the first positive clinical data from a new...

May 22, 2019

What is your brand's plan after patent expiration and pharma LOE?

Chidi Obiajulu

Medication switching by pharmacies can be one of the biggest challenges faced by loss of exclusivity(LOE)brands following patient expiration and the entrance of new generics in the marketplace.